- Cancer risk
- Gene mutant positive
- HOXB13 gene mutation
- Li-Fraumeni syndrome gene mutation
- Pathogenic gene mutation
- Cancer genetics
- Cancer risk evaluation
- HOXB13 risk evaluation
- Li Fraumeni risk evaluation
- Skin punch biopsy
Kara N. Maxwell, MD, PHD
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Rena Rowan Breast Center
Penn Medicine Provider
About me
- Assistant Professor of Medicine (Hematology-Oncology)
- Assistant Professor of Medicine in Genetics
My education and training
- NewYork-Presbyterian / Weill Cornell Medical CenterMedical School
- NewYork-Presbyterian/Columbia University Medical CenterResidency
- University of Pennsylvania Health SystemFellowship
Spoken languages
English
English
Reviews
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Maxwell is a Penn Medicine physician.
Qualifications and experience
- Medical Oncology, 2014
- American Association of Cancer Research, National
- American Cancer Society National Breast Cancer Roundtable Advisory Committee, National
- American Society of Clinical Oncology, National
- American Society of Human Genetics, National
- ClinGen TP53 Variant Classification Expert Panel (VCEP), International
- Facing Our Risk of Cancer Empowered (FORCE), National
- Li Fraumeni Syndrome Exploration Consortium, International
- Million Veterans Program Projects and Publications (P&P) Committee, Department of Veterans Affairs, National
- National Cancer Care Network (NCCN), National
- National Precision Oncology Program Molecular Tumor Board, Department of Veterans Affairs, National
- Cancer genetics and risk evaluation
Treatments and conditions
Research
Publications
Wang L, Desai H, Teerlink C, Clark O, Pridgen KM, VA Million Veteran Program, Lee J, Chang KM, Kember RL, Vujkovic M, Lynch JA, Maxwell KN Cross-ancestry and phenome-wide associations of cancer-specific polygenic risk scores , JCO Precis Oncol, 2025.05.15.25327704: 2026
Bailey AV, Frochen S, Kwan L, Siavoshi M, Haroldsen CL, Shelton JB, Rose B, Maxwell KN, Nickols NG, Yamoah K, Rebbeck TR, Schoen MW, Rettig MB, Vassy JL, Garraway IP, Iyer HS A Comparison of Prostate Cancer Incidence and Mortality Rates in the Veterans Affairs Healthcare system and the Surveillance, Epidemiology, and End Results Program , Cancer Epidemiol Biomarkers Prev: 2026
Schoen MW, Li J, Zeng S, Desai H, Hausler R, Haroldsen CL, Owens L, Valle LF, Etzoni RB, Rebbeck TR, Rose BS, Kelley MJ, Montgomery RB, Nickols NG, Rettig MB, Yamoah K, Maxwell KN, Garraway IP. Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate , JCO Precis Oncol, 10(7): 2026,e2600021
Valle LF, Scobie M, Rowe K, Pritchard CC, Montgomery B, Garraway IP, Nickols NG, Schoen MW, Kishan AU, Kelley MJ, Rettig MB, Maxwell KN. Interference of Clonal Hematopoiesis in cfDNA Liquid Biopsy Testing & Identification of Actionable Alterations in Large Diverse Cohort of US Veterans , Oncologist, oyag265: 2026
Buckley KH, Dungan ME, Dinh K, Kelly GM, Hausler R, Bennett KE, Clay DG, Youngman JE, Majer AD, Beyries KA, Niccum BA, Shaffer SM, Karakasheva TA, Hamilton KE, Kochman ML, Ginsberg GG, Ahmad N, Maxwell KN, Katona BW Gastric epithelium from BRCA1 and BRCA2 carriers harbors increased double-stranded DNA damage and augmented growth , Mol Cancer Res, 24(7): 2026,589-600
Pepin A, Doucette A, Narayan VK, Maxwell KN, Takvorian SU, O'Brien SR, Mankoff DA, Mulugeta PG, Taunk NK. Differential Response to (177)Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer , J Nucl Med, 67(6): 2026,926-928
MacFarland SP, Goodman VE, King-Dowling S, Zelley K, Crompton BD, Schultz KAP, Maese LD, Maxwell KN, Khincha PP, Schwartz LA. Liquid Biopsy for Cancer Screening in Li-Fraumeni Syndrome: Interest in Clinical Trial and Reported Barriers to Standard-of-Care Screening , Cancer Prev Res, 19(6): 2026,331-337
Cheng HH, Maxwell KN, Salari K, Cooperberg MR, Follmer K, Jeter JM, Jun G, Lee DJ, Patel HD, Schaeffer EM, Sokolova AO, Wolff EM, Lin DW. The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study , BJU Int: 2026
Moses R, Powers J, Levine AS, Garber JE, MacFarland SP, Rana HQ, Murphy ME, Maxwell KN. The biology of hypomorphic TP53 variants and implications for clinical management , Clin Cancer Res: 2026
Buckley KH, Zhu Y, Dinh K, Hausler R, Gala R, Spiegel SR, Delgado R, Clay DG, Kelly GM, Brower J, Domchek SM, Maxwell KN, Katona BW. Prevalence of Helicobacter pylori Exposure and Risk Factors Among BRCA1 and BRCA2 Carriers , Int J Cancer: 2026